A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: A Gynecologic Oncology Group study
D. Scott McMeekin, Michael W. Sill, Kathleen M. Darcy, Ovadia Abulafia, Parviz Hanjani, Michael L. Pearl, Stephen C. Rubin, Peter G. Rose, Laurie Small, Doris Mangiaracina Benbrook
Research output: Contribution to journal › Article › peer-review
18Scopus
citations
Fingerprint
Dive into the research topics of 'A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: A Gynecologic Oncology Group study'. Together they form a unique fingerprint.